OTCMKTS:AIMD Ainos (AIMD) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free AIMD Stock Alerts $1.05 +0.03 (+2.94%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$1.00▼$1.0750-Day Range$0.81▼$2.0552-Week Range$0.79▼$6.10Volume45,990 shsAverage Volume1.52 million shsMarket Capitalization$6.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesSEC Filings Get Ainos alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Ainos Stock (OTCMKTS:AIMD)Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Read More AIMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AIMD Stock News HeadlinesMarch 11, 2024 | msn.comSOS, MFG and LYT among pre-market losersMarch 10, 2024 | finance.yahoo.comAinos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)April 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 8, 2024 | finanznachrichten.deAinos, Inc.: Ainos Reports Full Year 2023 Financial ResultsMarch 8, 2024 | markets.businessinsider.comNasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In FebruaryMarch 4, 2024 | edition.cnn.comAinos IncFebruary 23, 2024 | benzinga.comAinos Stock (NASDAQ:AIMD), Short Interest ReportFebruary 8, 2024 | finance.yahoo.comSmall-Cap Growth Virtual Investor Conference Presentations Now Available for Online ViewingApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 1, 2024 | finance.yahoo.comAinos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7thJanuary 5, 2024 | msn.comUS Stocks Higher; Payrolls Increase By 216,000 In DecemberJanuary 5, 2024 | investorplace.comWhy Is Ainos (AIMD) Stock Up 157% Today?January 2, 2024 | finanznachrichten.deAinos, Inc.: Ainos Regains Compliance with Nasdaq Minimum Bid Price RequirementJanuary 2, 2024 | finance.yahoo.comAinos Regains Compliance with Nasdaq Minimum Bid Price RequirementDecember 26, 2023 | finance.yahoo.comAinos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of SmellDecember 12, 2023 | msn.comAinos implements a reverse stock splitDecember 12, 2023 | finance.yahoo.comAinos, Inc. Announces Stock ConsolidationNovember 28, 2023 | finance.yahoo.comAinos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss PharmaceuticalNovember 10, 2023 | msn.comAinos GAAP EPS of -$0.15November 9, 2023 | finance.yahoo.comAinos Reports Third Quarter 2023 Financial ResultsNovember 8, 2023 | morningstar.comAinos Inc AIMDNovember 6, 2023 | finance.yahoo.comAinos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONASeptember 25, 2023 | finance.yahoo.comAinos Announces Placement of Initial $3 Million Tranche of $10 Million Private PlacementSeptember 19, 2023 | finance.yahoo.comWith Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV PatientsSeptember 18, 2023 | finanznachrichten.deAinos, Inc.: Ainos' VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive PatientsSeptember 18, 2023 | finance.yahoo.comAinos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive PatientsSeptember 5, 2023 | finanznachrichten.deAinos, Inc.: Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in TaiwanSee More Headlines Receive AIMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:AIMD CUSIPN/A CIK1014763 Webwww.amarbio.com Phone(858) 869-2986Fax806-376-9301Employees46Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,010,000.00 Net Margins-515.80% Pretax Margin-515.76% Return on Equity-44.32% Return on Assets-40.35% Debt Debt-to-Equity Ratio0.08 Current Ratio1.92 Quick Ratio1.45 Sales & Book Value Annual Sales$122,112.00 Price / Sales52.83 Cash FlowN/A Price / Cash FlowN/A Book Value$1.50 per share Price / Book0.70Miscellaneous Outstanding Shares6,144,000Free Float13,322,000Market Cap$6.45 million OptionableNot Optionable Beta1.44 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Chun-Hsien Tsai (Age 54)Chairman of Board, President & CEO Comp: $112.12kMr. Lawrence Kennedy Lin (Age 55)Executive Vice President of Operations Comp: $144kMr. Hsin-Liang Lee (Age 53)Chief Financial Officer Mr. Chih-Heng Lu (Age 44)Director of Corporate Developoment Key CompetitorsXylo TechnologiesNASDAQ:MDGSEscalon MedicalOTCMKTS:ESMCBiotricityOTCMKTS:BTCYTherapix BiosciencesOTCMKTS:TRPXYHealthcare TriangleNASDAQ:HCTIView All CompetitorsInsidersTing-Chuan LeeBought 61,157 shares on 4/26/2023Total: $48,314.03 ($0.79/share) AIMD Stock Analysis - Frequently Asked Questions How have AIMD shares performed in 2024? Ainos' stock was trading at $2.05 on January 1st, 2024. Since then, AIMD stock has decreased by 48.8% and is now trading at $1.05. View the best growth stocks for 2024 here. When did Ainos' stock split? Shares of Ainos reverse split on the morning of Tuesday, August 9th 2022. The 1-15 reverse split was announced on Tuesday, August 9th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, August 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Ainos? Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:AIMD) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
